A team at the University of Minnesota has built a new kind of microfluidic chip—a device that moves tiny amounts of liquid through microscopic channels—that could make at-home medical testing faster, cheaper, and far more capable. Unlike many diagnostic systems that depend on pumps, valves, and other bulky hardware, this design works with very few components and can be powered wirelessly by a smartphone. That matters because one of the biggest barriers to more advanced home testing is complexity: the more moving parts a device needs, the harder it is to miniaturize, manufacture, and sell at a low cost. The researchers say their platform could eventually be used to detect viruses, bacteria, and other disease-related markers, called biomarkers, in liquid samples such as blood or urine. In principle, that could mean tests that do much more than today’s simple yes-or-no strips, including identifying a specific viral strain or measuring health indicators like glucose or cholesterol. The work arrives at a moment when the public has become much more aware of the value of rapid, point-of-care diagnostics—tests that can be done where the patient is, rather than in a centralized lab. And because the team is already working with a Minnesota startup to commercialize the technology, this is not just a laboratory proof of concept but an early look at what next-generation home diagnostics might become.
How the chip simplifies medical testing
Microfluidics is often described as a “lab on a chip” because it lets researchers perform laboratory-style analysis using minute amounts of fluid. The promise is huge: a drop of blood or urine could be enough to run a sophisticated test without sending the sample to a hospital lab.
But building these systems has been harder than it sounds. Many designs require multiple mechanical parts to push fluids around, and each extra component adds cost, size, and opportunities for failure.
Why smartphone power is a big deal
The Minnesota team’s approach stands out because the chip can be powered wirelessly by a smartphone. That removes the need for a dedicated power source or a larger supporting instrument, both of which can make home diagnostics more expensive and less convenient.
A smartphone is an especially useful partner because it is already packed with the features many portable medical tools need: power delivery, computing, data storage, connectivity, and a familiar user interface. In practical terms, that could make future tests easier to run and easier to connect with telemedicine or electronic health records.
What kinds of diseases and markers it could detect
The researchers say the platform is designed for broad use. It could potentially detect viruses, pathogens—a broad term for disease-causing organisms—bacteria, and other biomarkers found in liquid samples.
That flexibility is important because the same basic chip architecture could be adapted for many different tests. Instead of building an entirely new device for each condition, developers may be able to use one core platform and tailor it to different diseases or health measurements.
Beyond the rapid test strip
Today’s most familiar home diagnostics, such as rapid COVID-19 antigen tests, are useful because they are simple and fast. But they are also limited: they usually answer one narrow question and cannot easily deliver the richer information that clinicians often want.
More sophisticated chips could go further by identifying a particular strain of a virus or by measuring substances such as glucose and cholesterol. Those are examples of biomarkers, measurable signals in the body that can reveal infection, chronic disease, or overall health status.
From the lab toward commercialization
The project is already moving beyond academic research. Oh’s lab is working with Minnesota startup GRIP Molecular Technologies, a company that manufactures at-home diagnostic devices, to help commercialize the platform.
That industry connection matters because many promising medical technologies stall after publication. A company focused on manufacturing and product development can help translate a clever chip into something reliable, scalable, and practical for real patients.
What the researchers are saying
Lead author Christopher Ertsgaard, a recent University of Minnesota alumnus, framed the work in the context of lessons learned during the pandemic. He said the demand for rapid, at-home, point-of-care testing is now obvious, but current technologies still need to become faster, more sensitive, and more affordable.
He also pointed to manufacturing as a key advantage. If the chip can be produced at scale with high-density manufacturing methods, devices that once seemed too sophisticated for home use could become widely available at a lower cost.
Why This Matters
The biggest promise of this technology is access. If advanced diagnostic tools can be reduced to a chip and powered by a device people already own, testing could move closer to the patient, cutting wait times and lowering the burden on clinics and laboratories.
There is also a public health angle. Faster and more sensitive home tests could help people catch infections earlier, monitor chronic conditions more easily, and seek treatment sooner, all while generating better data for doctors and health systems.
The study was published in Nature Communications, an open-access, peer-reviewed journal from Nature Research, which gives the work scientific visibility and allows others to build on it. The next challenge will be proving that the platform performs reliably outside the lab, across many types of samples and real-world use cases. If that happens, smartphone-powered microchips could help redefine home testing from a simple screening tool into a more complete personal diagnostic system. In the coming years, the most important medical device in the house may not be a separate machine at all, but a tiny chip designed to work with the phone already in your pocket.